Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-08

FDA Approved: LAMOTRIGINE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for lamotrigine from Zydus Pharmaceuticals USA Inc. under an ANDA, indicating an approved change to the generic prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)